Safety and Efficacy of Ertugliflozin in Combination with Sitagliptin in Subjects with T2DM Inadequately Controlled on Diet and Exercise: The VERTIS SITA Trial

被引：0
|
作者：
Lauring, Brett
Miller, Sam S.
Krumins, Tania
Zhou, Hao Jin
Huyck, Susan
Johnson, Jeremy
Golm, Gregory
Terra, Steven G.
Mancuso, James P.
Engel, Samuel S.
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1197-P
引用
收藏
页码：A319 / A320
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of ertugliflozin in combination with sitagliptin in patients with type 2 diabetes inadequately controlled on diet and exercise: the VERTIS SITA trial
    Lauring, B.
    Miller, S. S.
    Krumins, T.
    Zhou, H. J.
    Huyck, S.
    Johnson, J.
    Golm, G.
    Terra, S. G.
    Mancuso, J. P.
    Engel, S. S.
    [J]. DIABETOLOGIA, 2017, 60 : S407 - S408
  • [2] Safety and Efficacy of Ertugliflozin after 52 Weeks in Subjects with T2DM Inadequately Controlled on Metformin and Sitagliptin: Results from the Extension Phase of the VERTIS SITA2 Trial
    Liu, Jie
    Eldor, Roy
    Dagogo-Jack, Samuel
    Amorin, Guillermo
    Johnson, Jeremy
    Liao, Yuqin
    Huyck, Susan
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    [J]. DIABETES, 2017, 66 : A35 - A35
  • [3] Efficacy and safety of ertugliflozin in subjects with type 2 diabetes mellitus inadequately controlled on the dual combination of metformin and sitagliptin: the VERTIS SITA2 trial
    Lauring, B.
    Eldor, R.
    Liu, J.
    Dagogo-Jack, S.
    Amorin, G.
    Johnson, J.
    Hille, D.
    Huyck, S.
    Golm, G.
    Terra, S.
    Mancuso, J.
    Engel, S. S.
    [J]. DIABETOLOGIA, 2016, 59 : S93 - S93
  • [4] Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study
    Aronson, Ronnie
    Frias, Juan
    Goldman, Allison
    Darekar, Amanda
    Lauring, Brett
    Terra, Steven G.
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (06): : 1453 - 1460
  • [5] Safety and Efficacy of Ertugliflozin plus Sitagliptin vs. Either Treatment Alone after 52 Weeks in Subjects with T2DM Inadequately Controlled on Metformin: VERTIS FACTORIAL Trial Extension
    Pratley, Richard E.
    Raji, Annaswamy
    Eldor, Roy
    Sunga, Sheila
    Qiu, Yanping
    Johnson, Jeremy
    Huyck, Susan
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    [J]. DIABETES, 2017, 66 : A34 - A34
  • [6] Safety and efficacy of ertugliflozin after 52 weeks in patients with type 2 diabetes inadequately controlled on metformin and sitagliptin: VERTIS SITA2 trial extension
    Eldor, R.
    Liu, J.
    Dagogo-Jack, S.
    Amorin, G.
    Johnson, J.
    Liao, Y.
    Huyck, S.
    Golm, G.
    Terra, S. G.
    Mancuso, J. P.
    Engel, S. S.
    Lauring, B.
    [J]. DIABETOLOGIA, 2017, 60 : S21 - S21
  • [7] Long-Term Efficacy and Safety of Ertugliflozin Monotherapy in Patients with Inadequately Controlled T2DM Despite Diet and Exercise: The 52-Week VERTIS MONO Study
    Frias, Juan
    Goldman, Allison
    Aronson, Ronnie
    Darekar, Amanda
    Lauring, Brett
    Huyck, Susan
    Terra, Steven
    [J]. DIABETES, 2017, 66 : A322 - A323
  • [8] Safety and efficacy of ertugliflozin plus sitagliptin versus either treatment alone in subjects with type 2 diabetes inadequately controlled with metformin: the VERTIS FACTORIAL trial
    Pratley, R.
    Eldor, R.
    Golm, G.
    Huyck, S.
    Qiu, Y.
    Sunga, S.
    Johnson, J.
    Terra, S.
    Mancuso, J.
    Engel, S. S.
    Lauring, B.
    [J]. DIABETOLOGIA, 2016, 59 : S347 - S347
  • [9] Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized study
    Dagogo-Jack, Samuel
    Liu, Jie
    Eldor, Roy
    Amorin, Guillermo
    Johnson, Jeremy
    Hille, Darcy
    Liao, Yuqin
    Huyck, Susan
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 530 - 540
  • [10] Efficacy and Safety of Sitagliptin in Hispanic Subjects with T2DM
    Raji, Annaswamy
    Long, Jianmin
    O'Neill, Edward A.
    Engel, Samuel S.
    [J]. DIABETES, 2017, 66 : A322 - A322
12345